Apo A-I inhibits foam cell formation in apo E-deficient mice after monocyte adherence to endothelium

Journal of Clinical Investigation

Volumn 104, Issue 1, 1999, Pages 31-39

  Dansky, Hayes M ^a   Charlton, Sherri A ^a   Barlow, Courtenay B ^a   Tamminen, Minna ^a   Smith, Jonathan D ^a   Frank, Joy S ^b   Breslow, Jan L ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL ADHESION; ELECTRON MICROSCOPY; ENDOTHELIUM; FEMALE; FOAM CELL; GENOTYPE; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNOHISTOCHEMISTRY; LIPID ANALYSIS; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0032716487     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6577     Document Type: Article

References (37)

1. Johnson, W.J., Mahlberg, F.H., Rothblat, G.H., and Phillips, M.C. 1991. Cholesterol transport between cells and high-density lipoproteins. Biochim. Biophys. Acta. 1085:273-298.
2. Pillarisetti, S., Paka, L., Obunike, J.C., Berglund, L., and Goldberg, I.J. 1997. Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix. J. Clin. Infest. 100:867-874.
3. Cockerill, G.W., Rye, K.A., Gamble, J.R., Vadas, M.A., and Barter, P.J. 1995. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler. Thromb. Vasc. Biol. 15:1987-1994.
4. Navab, M., et al. 1997. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio [published erratum appears in J. Clin. Invest. 1997. 99:3043]. J. Clin. Invest. 99:2005-2019.
5. Plump, A.S., Scott, C.J., and Breslow, J.L. 1994. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA. 91:9607-9611.
6. Paszty, C., Maeda, N., Verstuyft, J., and Rubin, E.M. 1994. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J. Clin. Invest. 94:899-903.
7. Plump, A.S., et al. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:343-353.
8. Zhang, S.H., Reddick, R.L., Piedrahita, J.A., and Maeda, N. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:468-471.
9. Nakashima, Y., Plump, A.S., Raines, E.W., Breslow, J.L., and Ross, R. 1994. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14:133-140.
10. Reddick, R.L., Zhang, S.H., and Maeda, N. 1994. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression [published erratum appears in Arterioscler. Thromb. 1994. 14:839]. Arterioscler. Thromb. 14:141-147.
11. Walsh, A., Ito, Y., and Breslow, J.L. 1989. High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3. J. Biol. Chem. 264:6488-6494.
12. Rubin, E.M., Ishida, B.Y., Clift, S.M., and Krauss, R.M. 1991. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Proc. Natl. Acad. Sci. USA. 88:434-438.
13. Tamminen, M., Mottino, G., Qiao, J.H., Breslow, J.L., and Frank, J.S. 1999. Ultrastructure of early lipid accumulation in apoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 19:847-853.
14. Nakashima, Y., Raines, E.W., Plump, A.S., Breslow, J.L., and Ross, R. 1998. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18:842-851.
15. Piedrahita, J.A., Zhang, S.H., Hagaman, J.R., Oliver, P.M., and Maeda, N. 1992. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89:4471-4475.
16. Dansky, H.M., Charlton, S.A., Harper, M.M., and Smith, J.D. 1997. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA. 94:4642-4646.
17. Nievelstein, P.F., Fogelman, A.M., Mottino, G., and Frank, J.S. 1991. Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. A deep-etch and immunolocalization study of ultrarapidly frozen tissue. Arterioscler. Thromb. 11:1795-1805.
18. Nievelstein-Post, P., Mottino, G., Fogelman, A., and Frank, J. 1994. An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit. Arterioscler. Thromb. 14:1151-1161.
19. Daugherty, A., et al. 1997. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/-mice. J. Clin. Invest. 100:1575-1580.
20. Roselaar, S.E., Kakkanathu, P.X., and Daugherty, A. 1996. Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/-mice. Decreasing density with disease progression. Arterioscler. Thromb. Vasc. Biol. 16:1013-1018.
21. Zhou, X., Stemme, S., and Hansson, G.K. 1996. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am. J. Pathol. 149:359-366.
22. Camejo, G., Hurt-Camejo, E., Wiklund, O., and Bondjers, G. 1998. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis. 139:205-222.
23. Khan, U.V., Parthasarathy, S.S., Alexander, R.W., and Medford, R.M. 1995. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J. Clin. Invest. 95:1262-1270.
24. Marui, N., et al. 1993. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92:1866-1874.
25. Baker, P.W., Rye, K.A., Gamble, J.R., Vadas, M.A., and Barter, P.J. 1999. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. J. Lipid Res. 40:345-353.
26. Ashby, D.T., et al. 1998. Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 18:1450-1455.
27. Kume, N., Cybulsky, M.I., and Gimbrone, M.A., Jr. 1992. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90:1138-1144.
28. Smith, J.D., et al. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. USA. 92:8264-8268.
29. Qiao, J.H., et al. 1997. Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. Am. J. Pathol. 150:1687-1699.
30. Gu, L., et al. 1998. Absence of monocyte chemoattractant prorein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell. 2:275-281.
31. Palinski, W., et al. 1994. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehydelysine in serum Arterioscler. Thromb. 14:605-616.
32. Boullier, A., et al. 1995. Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease. Clin. Chim. Acta. 238:1-10.
33. Watson, A.D., et al. 1995. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96:2882-2891.
34. Shih, D.M., et al. 1998. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature. 394:284-287.
35. Aviram, M., et al. 1998. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest. 101:1581-1590.
36. Stein, O., et al. 1997. Delayed loss of cholesterol from a localized lipoprotein depot in apolipoprotein A-I-deficient mice. Proc. Natl. Acad. Sci. USA. 94:9820-9824.
37. Stein, O., et al. Dexamethasone impairs cholesterol egress from a localized lipoprotein depot in vivo. Atherosclerosis. 137:303-310.